Published - Fri, 11 Nov 2022
Incidence: The ages of 20 and 24 have the highest frequency of the disease.
CLINICAL FEATURES
1. Local disease
a) Acute urethritis is the most common presentation in heterosexual men. Symptoms begin within 1 to 14 days of exposure and consist of dysuria and penile discharge. Three to ten percent of men with gonorrhea may be asymptomatic.
b) Cervicitis: Primary gonorrhea in women is usually asymptomatic, and when symptoms do occur, they are usually mild and non-specific. Up to 20% of women with primary gonorrhea develop pelvic inflammatory disease, and 33% to 81% of women with the pelvic inflammatory disease have gonorrhea.
c) Pharyngeal gonorrhea can be asymptomatic: The pharynx is colonized in 3% to 7% of heterosexual men, 5% to 20% of women, 10% to 25% of homosexual men, and 39% to 96% of pregnant women.
d) Anorectal gonorrhea is common in both heterosexual women and homosexual men and is often asymptomatic. When symptoms occur, they are usually mild pruritus and rectal discomfort.
2. Disseminated gonorrhea may complicate the disease course in 1% to 3% of patients with localized disease and is manifested most commonly as monoarticular arthritis or pustular dermatitis syndrome.
DIFFERENTIAL DIAGNOSES
1. Gonococcal urethritis must be differentiated from non-gonococcal urethritis caused by Chlamydia trachomatis.
2. Disseminated gonorrhea: N. meningitidis infection, acute rheumatic fever, and Reiter syndrome must be ruled out. Differential diagnoses for skin lesions include syphilis, HIV infection, and condyloma acuminata.
EVALUATION: Gram stain and culture of discharges are the cornerstones of diagnosis. All patients evaluated for gonorrhea should also have blood drawn for syphilis serology.
THERAPY: For uncomplicated cervicitis or urethritis:
1. Ceftriaxone (250 mg intramuscularly) and doxycycline (100 mg orally twice daily for 14 days, to cure possible concomitant Chlamydia infection) are the standard therapy.
2. Cefixime (400 mg orally in a single dose) is no longer an accepted alternative due to resistance.
3. Azithromycin, 2 g one-time dose, is an alternative for cephalosporin allergic patients.
DISPOSITION
1. Uncomplicated gonorrhea is managed on an outpatient basis. All sexual contacts must be identified and treated, and HIV testing should be considered by the patient with his or her primary physician at a later date.
2. Patients with disseminated gonorrhea require hospitalization.
Rigomo is a leading online education platform that offers a wide range of courses to help individuals enhance their skills and achieve their career goals. With our user-friendly interface and expert instructors, we strive to provide high-quality education to everyone, anytime and anywhere. Join us today and take the first step towards a brighter future.
Rigomo is an e-learning platform that was founded in 2019 by a team of dedicated professionals with a passion for revolutionizing the way people learn. The platform offers a range of online courses that cover various industries, including business, technology, healthcare, and more.
Rigomo's courses are designed to be interactive and engaging, with a focus on practical skills that learners can apply in their careers. The platform uses a combination of video lectures, quizzes, and hands-on projects to help learners master the subject matter.
Rigomo is committed to providing affordable and accessible education to people around the world. The platform offers a range of pricing options, including monthly and annual subscriptions, as well as pay-as-you-go options for individual courses.
Since its launch, Rigomo has received numerous accolades for its innovative approach to e-learning. The platform has helped thousands of learners across the globe acquire new skills and advance their careers.
As Rigomo continues to grow, the team remains committed to providing high-quality education that is accessible to all. The platform is constantly updating its courses and features to ensure that learners have access to the latest tools and technologies.
Sun, 12 May 2024
Thu, 25 Apr 2024
Wed, 24 Apr 2024
Write a public review